Low-frequency ultrasound waves directly manipulate blood flow properties
For decades, ultrasound has been associated with diagnostics – a routine scan in a hospital room, a monitor…
Human ‘hibernation gene’ could help reverse Type 2 diabetes, studies find
Two newly published studies offered an unexpectedly hopeful glimpse at the future of diabetes care: Humans may already…
Four OICR-funded studies explore transformative approaches in cancer care
Four new research studies funded by the Ontario Institute for Cancer Research (OICR) will deliver cutting-edge innovations by…
GLP-1s like Ozempic masked our cancer symptoms
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…
Diabetes drugs used for weight loss face growing concerns
Drugs developed for the treatment of type 2 diabetes or obesity-related conditions have stood out due to their…
Cardiometabolic diseases remain leading cause of excess American mortality
Between 1999 and 2022, the US had substantially higher death rates than other wealthy nations, largely due to…
Metformin targets the gut instead of the liver to lower glucose
For decades, physicians and scientists thought metformin, the leading Type 2 diabetes medication taken by millions worldwide, mainly…
Diabetes Detection Needs Better Tools. They’re on the Way
For decades, a diabetes diagnosis has relied largely on measuring blood sugar and seeing whether it crosses a…
Kyoto University identifies a key regulator of insulin production
A hallmark of Type 2 diabetes is the progressive loss of beta cell mass: cells in the pancreas…
Six genes found to connect pancreatic cancer with metabolic dysfunction
New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain…
App launched to track heart health after high-risk pregnancies
A new co-created digital companion aims to close the postpartum care gap by helping women monitor and manage…
Popular GLP-1 drugs significantly reduce major cardiovascular events,
Widely used diabetes and obesity drugs show powerful heart-protective effects in high-risk patients, offering new momentum for their…